title: Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts--time to implement in South Africa?
authors.affiliation: Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town. joejarvis@doctors.net.uk
authors.forename: Joseph N
authors.initials: JN
authors.lastname: Jarvis
authors.forename: Thomas S
authors.initials: TS
authors.lastname: Harrison
authors.forename: Nelesh
authors.initials: N
authors.lastname: Govender
authors.forename: Stephen D
authors.initials: SD
authors.lastname: Lawn
authors.forename: Nicky
authors.initials: N
authors.lastname: Longley
authors.forename: Tihana
authors.initials: T
authors.lastname: Bicanic
authors.forename: Gary
authors.initials: G
authors.lastname: Maartens
authors.forename: Francois
authors.initials: F
authors.lastname: Venter
authors.forename: Linda-Gail
authors.initials: LG
authors.lastname: Bekker
authors.forename: Robin
authors.initials: R
authors.lastname: Wood
authors.forename: Graeme
authors.initials: G
authors.lastname: Meintjes
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D015897:Comorbidity; D003454:Cryptococcus; D015658:HIV Infections / Q000453:epidemiology* / Q000276:immunology; D006801:Humans; D008403:Mass Screening / Q000706:statistics & numerical data*; D016919:Meningitis, Cryptococcal / Q000175:diagnosis* / Q000453:epidemiology*; D013019:South Africa
chemical_list: D044966:Anti-Retroviral Agents